Terry Chemicals processes a single raw material, Clean-Z, in Department 1 of its main production facility. Out of the joint process in Department 1, two products emerge: Azyne and Bethanol. Azyne is further processed in Department 2, which also is a joint production process. After processing in Department 2, two products emerge: AzynePlus and Byzyne. AzynePlus is further processed in Department 3. Bethanol is processed further in Department 4. AzynePlus and Bethanol are considered main products. Byzyne is considered a by-product of AzynePlus. Information on the most recent period's production processes follows:

In Department 1, 237,000 units of the raw material Clean-Z are processed at a total cost of $1,650,300. After processing in Department 1, 60 percent of the units are transferred to Department 2, and 40 percent of the units (now unprocessed Bethanol) are transferred to Department 4.

In Department 2, the materials received from Department 1 are processed at an additional cost of $490,800. Seventy percent of the units become AzynePlus and are transferred to Department 3. The remaining 30 percent emerge as Byzyne and are sold at $12.90 per unit. The additional processing costs to make Byzyne salable are $108,060.

In Department 3, AzynePlus is processed at an additional cost of $213,648. After this processing, AzynePlus can be sold for $36 per unit.

In Department 4, Bethanol is processed at an additional cost of $2,085,000. A normal loss of 10 percent of the units of good output of Bethanol occurs in this department. The remaining good output is then sold for $78 per unit.

Required:

Prepare a schedule showing the allocation of the $1,650,300 joint cost to AzynePlus and Bethanol using the estimated net realizable value approach. Revenue from the sale of by-products should be credited to the manufacturing costs of the related main product (method 1 in the text).

PLEASE ANSWER ASAP BY NOON TOMORROW

PLEASE MAKE SURE ALL OF THE NUMBERS ARE CORRECT

Complete this question by entering your answers in the tabs below. Prepare a schedule showing the allocation of the $1,650,300 joint cost to AzynePlus and Bethanol using the estimated net realizable value approach. Revenue from the sale of by-products should be credited to the manufacturing costs of the related main product. Note: Do not round intermediate calculations. Amounts to be deducted should be indicated by a minus sign. Round your units to the nearest whole unit. Complete this question by entering your answers in the tabs below. Determine the cost allocation for each product. Note: Do not round intermediate calculations. Round final answers to nearest whole dollars